Monotherapy with the vitamin D analogue MC1288 does not result in prolonged kidney allograft survival in rhesus monkeys

Transplant International : Official Journal of the European Society for Organ Transplantation
Michel VierboomMargreet Jonker

Abstract

The active form of vitamin D3, 1,25(OH)2D3, has pronounced immunoregulatory properties and is a potential treatment of immune-based disorders. However, the central role of this hormone in calcium and bone metabolism complicates its long-term use as an immunomodulator. Some newly developed vitamin D3-derived analogues, such as MC1288, have an improved immunoregulatory potential and prolong allograft survival in rodent models. Such compounds might be a valuable component of immunosuppressive treatment regimen in transplantation and autoimmunity. The rhesus monkey provides a useful model for the preclinical validation of new therapeutic strategies for transplantation. The present study shows that MC1288 inhibits both proliferation and interferon-gamma production by rhesus peripheral blood mononuclear cells in a mixed lymphocyte reaction. We have tested the maximum tolerated dose of MC1288 in a rhesus monkey model of kidney transplantation. The observed effects on serum calcium and parathyroid hormone confirm the in vivo activity of MC1288. However, as a monotherapy, MC1288 did not cause prolongation of the kidney allograft survival in rhesus monkeys.

References

Jan 1, 1994·Transplant International : Official Journal of the European Society for Organ Transplantation·C Johnsson, G Tufveson
Mar 20, 1998·The New England Journal of Medicine·M K ThomasJ S Finkelstein
Jun 12, 1998·The New England Journal of Medicine·J A Fishman, R H Rubin
Apr 13, 1999·Lancet·M D DentonM H Sayegh
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G Penna, L Adorini
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·L PiemontiV Di Carlo
Aug 17, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Penn
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S GregoriL Adorini
Nov 2, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A J Brown
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Luis GracaHerman Waldmann
Jul 10, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Heinz Wiendl, Reinhard Hohlfeld
Aug 22, 2002·International Immunopharmacology·Luciano Adorini
Jun 9, 2004·Drug Discovery Today·Bert A 't HartMargreet Jonker
Jul 13, 2004·Science·Ralph M Steinman, Ira Mellman
Sep 16, 2005·Transplant International : Official Journal of the European Society for Organ Transplantation·Debra A HullettBryan N Becker

❮ Previous
Next ❯

Citations

Jul 1, 2007·Expert Review of Clinical Immunology·Luciano AdoriniGiuseppe Penna

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
M R HausslerP W Jurutka
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
C A RedaelliJ F Dufour
© 2022 Meta ULC. All rights reserved